Physician profile
Robert Patrick Devoe
NPI 1366442147
$730.79
in general payments reported to CMS, 2019-2025
11 companies · $187 in 2025
The $187 reported for 2025 was more than what 79% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $255 · 2023: $102 · 2024: $187 · 2025: $187.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $476.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $476.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $181.98 | 2022-2024 | Carto 3 |
| Takeda Pharmaceuticals U.S.A., INC. | $126.15 | 2022-2024 | Entyvio |
| Stryker Corporation | $93.09 | 2022-2023 | Accolade, Tritanium |
| Zimmer Biomet Holdings, INC. | $84.54 | 2025 | Rosa, Z1 Hip System, Osseotite |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $63.27 | 2024-2025 | Xifaxan, Plenvu, Trulance |
| Regeneron Healthcare Solutions, INC. | $56.01 | 2023-2024 | Dupixent |
| Qol Medical, LLC | $33.15 | 2025 | Sucraid |
| Janssen Pharmaceuticals, INC | $31.34 | 2025 | Tremfya |
| Pacira Pharmaceuticals Incorporated | $26.97 | 2023 | Exparel |
| Cvrx, INC. | $20.69 | 2024 | Barostim Neo System |
| Conmed Corporation | $13.60 | 2025 | Airseal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Devoe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.